Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorCARROUEL, Florence
dc.contributor.authorDZIADZKO, Mikhail
dc.contributor.authorGRÉGOIRE, Charles
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGALINSKI, Michel
IDREF: 077593561
dc.contributor.authorDUSSART, Claude
dc.contributor.authorLVOVSCHI, Virginie-Eve
dc.date.accessioned2023-11-13T11:53:58Z
dc.date.available2023-11-13T11:53:58Z
dc.date.issued2023-11-01
dc.identifier.issn1950-6007en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/184727
dc.description.abstractEnProton-pump inhibitors (PPI) are frequently used in the emergency and general practice settings in several clinical presentations linked to acute upper gastro-intestinal tract disorders as abdominal or chest pain without recommendations. The aim of this scoping review was to assess pain reduction, diagnostic performance, and safety in the first 24 h-management in primary care or emergency medicine. Search was realized by 2 independent reviewers in PubMed, Embase, and Web of Science following PRISMA-ScR guidelines. Only original articles or systematic reviews in English were included. Studies about chronic and/or bleeding conditions, therapeutic cocktails and studies without pain evaluation were excluded. Two methodologies were used for bias estimation. From 4442 titles, 79 full-text articles were assessed, and 9 were included. There is no strong evidence supporting the use of PPI as a first line analgesic or diagnostic test in acute syndromes linked to acute upper gastro-intestinal tract disorder. A small effect in pain reduction was retrieved in patients with low pain scores. A poor additional value in patients with gastric reflux, and a low specificity compared to other diagnostic tests were observed. A short-term PPI administration appears to be safe with low risk of serious allergic reactions, and poor adverse effects (moderate evidence). Although PPIs may contribute to the multimodal analgesia in acute settings, with few and/or minor side effects, no recommendation can be drawn for their use as a primary analgesic. Data regarding the relevance of the PPI test are much less clear, no data regarding care pathways are available.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enHumans
dc.subject.enProton Pump Inhibitors
dc.subject.enAcute Disease
dc.subject.enGastrointestinal Diseases
dc.subject.enPain
dc.subject.enAnalgesics
dc.title.enRelevance of early management by proton-pump inhibitor in acute upper gastro-intestinal tract disorder: A scoping review
dc.title.alternativeBiomed Pharmacotheren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.biopha.2023.115523en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed37742610en_US
bordeaux.journalBiomedicine and Pharmacotherapyen_US
bordeaux.page115523en_US
bordeaux.volume167en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEADen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Biomedicine%20and%20Pharmacotherapy&rft.date=2023-11-01&rft.volume=167&rft.spage=115523&rft.epage=115523&rft.eissn=1950-6007&rft.issn=1950-6007&rft.au=CARROUEL,%20Florence&DZIADZKO,%20Mikhail&GR%C3%89GOIRE,%20Charles&GALINSKI,%20Michel&DUSSART,%20Claude&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record